s6y
Company name or ticker
Search
OPIANT PHARMACEUTICALS, INC.
PREM14A
Preliminary proxy statement relating to a merger, acquisition, or disposition
Filed
Wednesday, December 21, 2022
Period
Dec 20, 2022
Accession number
0001385508-22-000145
Documents
PREM14A
PREM14A
EX-FILING FEES
EX-FILING FEES
On sec.gov
Filing index
All files
Complete submission text
SGML header